Zhuang, H., Shi, S., Guo, Y., & Wang, Z. (2019). Increase of secondary mutations may be a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor. J Cancer.
Chicago-tyylinen lähdeviittausZhuang, Hongqing, Siyu Shi, Yihang Guo, ja Zhongqiu Wang. "Increase of Secondary Mutations May Be a Drug-resistance Mechanism for Lung Adenocarcinoma After Radiation Therapy Combined With Tyrosine Kinase Inhibitor." J Cancer 2019.
MLA-viiteZhuang, Hongqing, Siyu Shi, Yihang Guo, ja Zhongqiu Wang. "Increase of Secondary Mutations May Be a Drug-resistance Mechanism for Lung Adenocarcinoma After Radiation Therapy Combined With Tyrosine Kinase Inhibitor." J Cancer 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.